IMGT is researching and developing an ultrasound-guided therapy technology that bridges and utilizes the advantages in both Focused ultrasound & nanoparticle technology. Genetic therapy and drug delivery systems that can selectively express therapeutic agents using Focused ultrasound device to target desired treatment areas are laying the foundation for growth into the next generation of biomedical advancements.

Together with our determined fellow IMGT executives and employees, we will continue to challenge to improve the health and quality of life of the people by combining nanoparticle technology and Focused ultrasound technology. We will do their best to fulfill our duty as leaders in our field and become the best in class in the new medical paradigm of IMage Guided Therapy.

With Many Thanks

Hak Jong Lee, MD, PhD, MBA

CEO